Modern medicine has become extraordinarily good at finding things. High-resolution ultrasound can detect thyroid nodules smaller than a centimeter. Advanced pathology can identify cellular abnormalities that previous generations of physicians would never have seen. But the ability to detect is not the same as the ability to help. And in the space between detection and meaningful disease lies a problem that medicine is only beginning to confront: overdiagnosis.
The Detection Paradox
Overdiagnosis occurs when a condition is correctly identified but would never have caused symptoms, harm, or death during the patient's lifetime. It is not a misdiagnosis — the pathology is real. But the clinical significance is not.
The paradox is that better technology leads to more detection, more detection leads to more diagnosis, and more diagnosis leads to more treatment — even when the underlying disease burden has not changed. We are treating more thyroid cancer than ever before, but we are not reducing thyroid cancer mortality. The epidemic, in many cases, is one of diagnosis rather than disease.
The Human Cost of Knowing
Once a patient has been told they have cancer, everything changes. The word itself carries a weight that no amount of reassurance can fully lift. Patients who are told they have a "low-risk" or "indolent" cancer often experience the same levels of anxiety as those with aggressive disease. The label matters more than the prognosis.
This is the hidden cost of overdiagnosis: not just the physical consequences of unnecessary treatment — surgical scars, lifelong medication, potential complications — but the psychological burden of living with a cancer diagnosis that may never have affected one's health. For some patients, the diagnosis itself becomes the disease.
A Path Forward
Addressing overdiagnosis requires action on multiple fronts. It means developing better risk stratification tools that distinguish between cancers that need treatment and those that do not. It means rethinking screening guidelines to balance the benefits of early detection against the harms of overdiagnosis. And it means changing the language we use — because calling something "cancer" when it behaves nothing like the cancers patients fear may be one of the most consequential labels in medicine.
The instinct to find and fix is deeply embedded in medical culture. But the evidence increasingly suggests that in some cases, the most courageous and compassionate thing a physician can do is to say: "We found something, and the best thing we can do right now is watch it." That is not inaction. It is precision.